Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197762) titled 'MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: Emory University
Condition:
Neisseria Meningitidis
Intervention:
Biological: Trumenba
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 2025
Target Sample Size: 125
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07197762
Published by HT Digital Content Serv...